Using this in vitro system in combination with quantitative live-cell imaging, we discovered a reduced transport from the ER to the plasma membrane (PM) as a common cellular pathomechanism for both well-known renal failure–causing CRB2 variants and CRB2 variants with a predicted but so far non-validated pathogenic potential. The gene discussed is CRB2; the disease is kidney failure.